Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, weight loss drugs
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.
FDA Issues New Warning For Popular Weight Loss Drugs—Here's What You Need To Know
The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to stay safe before surgeries
Medicaid covers GLP-1 weight-loss drugs in just 13 states
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.
Can new weight loss drugs fight the US obesity epidemic? Here's what to know
Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer new weight loss drugs?
FDA adds new warning to popular weight loss drugs
The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy. President-elect Donald Trump has sent mixed signals for years on whether he would fire or demote Jerome Powell.
AOL
10d
Compounded GLP-1s for Weight Loss: What Are They and Are They Safe?
Compounded
GLP
-1s
for Weight
Loss
: What Are They and Are They Safe?
GLP
-1s (glucagon-like peptide-
1
receptor agonists ... involves changing or adding
new
ingredients to a medication or ...
10d
Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries
The odds for aspiration is greatest in the first weeks after a GLP-1 med is prescribed, since the delay in stomach emptying ...
Soap Central on MSN
11d
Smoothie King launches new menu for Ozempic and other GLP-1 weight loss supplement users
On October 29, Smoothie King announced the launch of new smoothies that support individuals with weight management goals.
Crain's Chicago Business
9d
Endevica bets it has a weight-loss drug to beat GLP-1s with spinoff
A new Northbrook pharma will work to bring its obesity treatment to market that it says holds advantages over Ozempic and its ...
New Atlas
16h
Weight-loss pill passes important safety test in clinical trial
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Outsourcing-pharma
10d
Competitors race to launch GLP-1 drugs amid soaring weight loss demand
Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback